Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-24 @ 4:52 PM
NCT ID:
NCT02799550
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 60 years
* Patient with relapsed and/or refractory CD19 positive B-cell acute lymphoblastic leukemia (B-ALL)
* Estimated life expectancy ≥ 12 weeks (according to investigator's judgment)
* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
Exclusion Criteria:
* Previous treatment with investigational gene or cell therapy medicine products
* CD19 negative B-cell leukemia
* Any uncontrolled active medical disorder that would preclude participation as outlined
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT02799550
Study Brief:
Protocol Section:
NCT02799550